The present invention is directed to new bicyclic compounds of the formula [I],
and pharmaceutically acceptable salts thereof wherein R1, R2, R3, R4, R5, R6, R7, Q1 Q2 and Q3 are as defined in the claims. The compounds have N-myristoyltransferase inhibitory and antifungal activity.
The present invention is directed to new bicyclic compounds of formula (I), and pharmaceutically acceptable salts thereof wherein R?1, R2, R3, R4, R5, R6, R7, Q1 Q2 and Q3¿ are as defined in the claims. The compounds have N-myristoyltransferase inhibitory and antifungal activity.
Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N -myristoyltransferase. Part 1
Potent and selectiveCandidaalbicansN-myristoyltransferase (CaNmt) inhibitors have been identified through optimization of a lead compound 1 discovered by random screening. The inhibitordesign is based on the crystal structure of the CaNmt complex with compound (S)-3 and structure-activity relationships (SARs) have been clarified. Modification of the C-4 side chain of 1 has led to the discovery